Benitec Biopharma (BNTC) Short Interest Ratio & Short Volume $10.68 +0.28 (+2.69%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Benitec Biopharma Short Interest DataBenitec Biopharma (BNTC) has a short interest of 56,900 shares. This marks a 48.95% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 45,625 shares to cover all short positions.Current Short Interest56,900 sharesPrevious Short Interest38,200 sharesChange Vs. Previous Month+48.95%Dollar Volume Sold Short$598,019.00Short Interest Ratio2.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares10,560,000 sharesPercentage of Shares Shorted0.54%Today's Trading Volume45,344 sharesAverage Trading Volume45,625 sharesToday's Volume Vs. Average99% Short Selling Benitec Biopharma? Sign up to receive the latest short interest report for Benitec Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNTC Short Interest Over TimeBNTC Days to Cover Over TimeBNTC Percentage of Float Shorted Over Time Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Benitec Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202456,900 shares $598,019.00 +49.0%N/A2 $10.51 10/15/202438,200 shares $374,742.00 -28.1%N/A1.3 $9.81 9/30/202453,100 shares $487,989.00 -10.2%N/A2 $9.19 9/15/202459,100 shares $481,665.00 -4.7%N/A2.6 $8.15 8/31/202462,000 shares $573,190.00 -6.8%N/A2.1 $9.25 8/15/202466,500 shares $571,900.00 -2.2%N/A2 $8.60 Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/202468,000 shares $599,760.00 -18.2%N/A1.8 $8.82 7/15/202483,100 shares $847,620.00 -10.0%3.7%2 $10.20 6/30/202492,300 shares $645,177.00 +871.6%4.1%0.9 $6.99 6/15/20249,500 shares $69,445.00 -25.8%0.4%0.1 $7.31 5/31/202412,800 shares $97,920.00 -77.2%0.6%0.1 $7.65 5/15/202456,100 shares $496,485.00 -43.1%2.5%0.6 $8.85 4/30/202498,500 shares $832,325.00 +707.4%6.3%1.2 $8.45 4/15/202412,200 shares $59,902.00 +10.9%0.5%0.2 $4.91 3/31/202411,000 shares $57,750.00 +115.7%0.5%0.7 $5.25 3/15/20245,100 shares $26,010.00 -68.3%0.2%0.4 $5.10 2/29/202416,100 shares $78,085.00 +151.6%0.7%1.1 $4.85 2/15/20246,400 shares $18,432.00 -18.0%0.3%0.5 $2.88 1/31/20247,800 shares $21,918.00 +25.8%0.3%0.9 $2.81 1/15/20246,200 shares $18,166.00 -18.4%0.3%0.7 $2.93 12/31/20237,600 shares $24,548.00 -39.7%0.3%0.7 $3.23 12/15/202312,600 shares $42,462.00 +5.9%0.6%1.1 $3.37 11/30/202311,900 shares $37,842.00 -64.4%0.5%0.8 $3.18 11/15/202333,400 shares $125,918.00 -28.2%1.5%1.6 $3.77 10/31/202346,500 shares $167,865.00 -20.7%3.1%0.6 $3.61 10/15/202358,600 shares $199,826.00 -13.7%3.9%0.1 $3.41 9/30/202367,900 shares $205,173.43 -24.7%4.6%0.1 $3.02 9/15/202390,200 shares $285,032.00 -33.8%6.1%0.1 $3.16 8/31/2023136,300 shares $402,085.00 -51.1%9.2%0.2 $2.95 8/15/2023278,500 shares $749,165.00 +52.2%N/A0.4 $2.69 7/31/2023183,000 shares $563,640.00 -81.2%N/A0.3 $3.08 7/15/2023974,300 shares $223,991.57 -57.3%N/A0.3 $0.23 6/30/20232,280,000 shares $543,780.00 +1,061.5%N/A0.7 $0.24 6/15/2023196,300 shares $46,110.87 -22.8%N/A0.1 $0.23 5/31/2023254,300 shares $61,311.73 -19.9%N/A0.9 $0.24 5/15/2023317,400 shares $67,856.95 -5.8%N/A1.1 $0.21 4/30/2023337,000 shares $67,770.70 +77.9%N/A1 $0.20 4/15/2023189,400 shares $40,436.71 +73.4%N/A0.6 $0.21 3/31/2023109,200 shares $22,921.08 -45.0%N/A0.4 $0.21 3/15/2023198,700 shares $46,694.50 -52.5%N/A0.6 $0.24The Crypto That’s Making Wall Street Sweat (Ad)The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth 2/28/2023418,700 shares $125,610.00 +101.1%N/A0.9 $0.30 2/15/2023208,200 shares $47,760.87 -3.6%N/A0.5 $0.23 1/31/2023215,900 shares $49,657.00 -1.7%N/A0.5 $0.23 1/15/2023219,600 shares $50,925.24 +109.9%N/A0.4 $0.23 12/30/2022104,600 shares $17,782.00 +245.2%N/A0.2 $0.17 12/15/202230,300 shares $4,545.00 -85.3%N/A0.1 $0.15 11/30/2022206,400 shares $42,312.00 +24.9%N/A0.3 $0.21 11/15/2022165,200 shares $28,596.12 -50.6%N/A0.3 $0.17 10/31/2022334,500 shares $58,637.85 +310.4%4.5%0.6 $0.18 10/15/202281,500 shares $19,486.65 -35.1%1.1%0.2 $0.24 9/30/2022125,600 shares $46,685.52 +187.4%2.1%0.4 $0.37 9/15/202243,700 shares $18,747.30 -87.7%0.6%0 $0.43 8/31/2022354,900 shares $262,519.53 +26.8%5.0%0.2 $0.74 8/15/2022279,900 shares $236,529.50 +353.7%4.0%0.1 $0.85 7/31/202261,700 shares $55,462.13 -40.1%0.9%0 $0.90 7/15/2022103,000 shares $110,210.00 -92.5%1.5%0 $1.07 6/30/20221,370,000 shares $1.59 million +13,738.4%19.5%0.6 $1.16 6/15/20229,900 shares $8,613.99 +23.8%0.1%0 $0.87 5/31/20228,000 shares $8,400.00 +281.0%0.1%0.3 $1.05 5/15/20222,100 shares $2,486.61 -56.3%0.0%0.1 $1.18 4/30/20224,800 shares $7,200.00 +166.7%0.1%0.2 $1.50 4/15/20221,800 shares $3,597.30 -67.9%0.0%0.1 $2.00 3/31/20225,600 shares $13,076.00 +75.0%0.1%0.2 $2.34 3/15/20223,200 shares $6,624.00 -70.1%0.1%0.1 $2.07 2/28/202210,700 shares $24,824.00 -17.1%0.2%0.3 $2.32 2/15/202212,900 shares $34,959.00 +84.3%0.2%0.4 $2.71 1/31/20227,000 shares $17,150.00 -77.4%0.1%0.2 $2.45 1/15/202231,000 shares $79,360.00 +121.4%0.4%0.8 $2.56 12/31/202114,000 shares $36,680.00 +17.7%0.2%0.4 $2.62 12/15/202111,900 shares $34,391.00 -13.1%0.2%0.3 $2.89 11/30/202113,700 shares $41,922.00 -9.3%0.2%0.1 $3.06 11/15/202115,100 shares $51,944.00 -29.8%0.2%0.1 $3.44 10/29/202121,500 shares $78,690.00 -21.3%0.3%0.2 $3.66 10/15/202127,300 shares $98,007.00 -1.1%0.4%0.2 $3.59 9/30/202127,600 shares $98,532.00 -78.0%0.4%0.2 $3.57 9/15/2021125,700 shares $487,716.00 -19.5%1.9%0.7 $3.88 8/31/2021156,200 shares $618,552.00 -25.1%3.9%1.5 $3.96 8/13/2021208,400 shares $827,348.00 +7.1%5.2%2 $3.97 7/30/2021194,600 shares $681,100.00 -2.5%4.9%0.7 $3.50 7/15/2021199,500 shares $758,100.00 -14.2%5.0%0.6 $3.80 6/30/2021232,400 shares $987,700.00 -18.1%5.8%0.6 $4.25 6/15/2021283,800 shares $1.25 million -19.8%7.1%0.4 $4.40 5/28/2021354,000 shares $1.67 million -6.4%8.9%0.1 $4.71 5/14/2021378,000 shares $1.77 million -0.2%9.5%0.1 $4.69 4/30/2021378,700 shares $1.61 million +35.0%12.0%0.1 $4.25 4/15/2021280,600 shares $1.46 million +21.0%7.8%0.1 $5.21 3/31/2021232,000 shares $997,600.00 +422.5%6.0%0.1 $4.30 3/15/202144,400 shares $146,076.00 +45.6%1.0%0 $3.29 2/26/202130,500 shares $106,902.50 -13.4%0.7%0.1 $3.51 2/12/202135,200 shares $174,592.00 +9.7%N/A0.1 $4.96We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 1/29/202132,100 shares $130,005.00 +79.3%2.3%0.1 $4.05 1/15/202117,900 shares $65,335.00 -57.8%1.3%0 $3.65 12/31/202042,400 shares $134,832.00 +480.8%3.2%0.1 $3.18 12/15/20207,300 shares $19,856.00 -84.9%0.5%0 $2.72 11/30/202048,400 shares $142,296.00 +44.9%3.6%0.1 $2.94 11/15/202033,400 shares $96,038.36 +475.9%2.5%0.1 $2.88 10/30/20205,800 shares $15,950.00 -68.0%0.4%0.1 $2.75 10/15/202018,100 shares $52,490.00 -54.6%1.4%0.2 $2.90 9/30/202039,900 shares $250,572.00 +100.5%3.6%0.6 $6.28 9/15/202019,900 shares $118,846.78 +19.9%1.3%1.5 $5.97 8/31/202016,600 shares $115,536.00 +1,409.1%1.0%0.6 $6.96 8/14/20201,100 shares $9,042.00 -79.6%0.1%0 $8.22 7/31/20205,400 shares $38,556.00 +3.9%0.3%0.2 $7.14 7/15/20205,200 shares $36,244.00 +44.4%0.3%0.2 $6.97 6/30/20203,600 shares $28,728.00 +414.3%0.2%0.1 $7.98 6/15/2020700 shares $5,656.00 -82.9%0.0%0 $8.08 5/29/20204,100 shares $28,987.00 -65.6%0.3%0.1 $7.07 5/15/202011,900 shares $99,484.00 +271.9%0.8%0.2 $8.36 4/30/20203,200 shares $29,120.00 +10.3%0.0%0 $9.10 4/15/20202,900 shares $15,704.37 -71.3%N/A0 $5.42 3/31/202010,100 shares $110,393.00 +405.0%N/A0.1 $10.93 3/13/20202,000 shares $8,800.00 -13.0%N/A0.1 $4.40 2/28/20202,300 shares $7,291.00 -32.4%N/A0 $3.17 2/14/20203,400 shares $14,144.00 +240.0%N/A0 $4.16 1/31/20201,000 shares $4,490.00 -16.7%N/A0 $4.49 1/15/20201,200 shares $6,300.00 -87.0%N/A0.1 $5.25 12/31/20199,200 shares $42,780.00 +95.7%N/A0.6 $4.65 BNTC Short Interest - Frequently Asked Questions What is Benitec Biopharma's current short interest? Short interest is the volume of Benitec Biopharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 56,900 shares of BNTC short. Learn More on Benitec Biopharma's current short interest. What is a good short interest ratio for Benitec Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTC shares currently have a short interest ratio of 2.0. Learn More on Benitec Biopharma's short interest ratio. Is Benitec Biopharma's short interest increasing or decreasing? Benitec Biopharma saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 56,900 shares, an increase of 49.0% from the previous total of 38,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Benitec Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Benitec Biopharma: Cartesian Therapeutics, Inc. (17.19%), C4 Therapeutics, Inc. (8.29%), Valneva SE (0.06%), Organogenesis Holdings Inc. (12.59%), 4D Molecular Therapeutics, Inc. (15.74%), MeiraGTx Holdings plc (2.56%), Akebia Therapeutics, Inc. (6.80%), Canopy Growth Co. (9.77%), Voyager Therapeutics, Inc. (5.41%), Sage Therapeutics, Inc. (11.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Benitec Biopharma stock? Short selling BNTC is an investing strategy that aims to generate trading profit from Benitec Biopharma as its price is falling. BNTC shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Benitec Biopharma? A short squeeze for Benitec Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTC, which in turn drives the price of the stock up even further. How often is Benitec Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTC, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies RNAC Short Interest Data CCCC Short Interest Data VALN Short Interest Data ORGO Short Interest Data FDMT Short Interest Data MGTX Short Interest Data AKBA Short Interest Data CGC Short Interest Data VYGR Short Interest Data SAGE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNTC) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
